We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 19.00 | 1.07% | 1,799.50 | 1,796.00 | 1,796.50 | 1,799.50 | 1,780.00 | 1,784.00 | 9,804,173 | 16:35:21 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 15.00 | 73.94B |
From May 2019 to May 2024
TIDMGSK
RNS Number : 8651N
GlaxoSmithKline PLC
11 May 2018
GlaxoSmithKline plc (the 'Company')
Transaction notification
Hot Features
Premium
1. Details of PDMR/person closely associated
with them ('PCA')
=== ==============================================================
a) Name Ms E Walmsley
=== ====================== ======================================
b) Position/status Chief Executive Officer
=== ====================== ======================================
c) Initial notification/ Initial notification
amendment
=== ====================== ======================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== ==============================================================
a) Name GlaxoSmithKline plc
=== ====================== ======================================
b) LEI 5493000HZTVUYLO1D793
=== ====================== ======================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== ==============================================================
a) Description Ordinary shares of 25 pence each
of the financial ('Ordinary Shares')
instrument ISIN: GB0009252882
=== ====================== ======================================
b) Nature of Acquisition of Ordinary Shares
the transaction under the Company's Share Reward
Plan.
=== ====================== ======================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------- -----------------------
GBP14.6664 9 (partnership shares)
----------- -----------------------
GBP14.6664 9 (matching shares)
----------- -----------------------
=== ====================== ======================================
d) Aggregated
information
Aggregated
volume Price
18 Ordinary Shares
GBP14.6664
=== ====================== ======================================
e) Date of the 2018-05-10
transaction
=== ====================== ======================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ====================== ======================================
1. Details of PDMR/person closely associated
with them ('PCA')
=== ==============================================================
a) Name Mr R G Connor
=== ====================== ======================================
b) Position/status President, Global Manufacturing
& Supply
=== ====================== ======================================
c) Initial notification/ Initial notification
amendment
=== ====================== ======================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== ==============================================================
a) Name GlaxoSmithKline plc
=== ====================== ======================================
b) LEI 5493000HZTVUYLO1D793
=== ====================== ======================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== ==============================================================
a) Description Ordinary shares of 25 pence each
of the financial ('Ordinary Shares')
instrument ISIN: GB0009252882
=== ====================== ======================================
b) Nature of Acquisition of Ordinary Shares
the transaction under the Company's Share Reward
Plan.
=== ====================== ======================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------- -----------------------
GBP14.6664 9 (partnership shares)
----------- -----------------------
GBP14.6664 9 (matching shares)
----------- -----------------------
=== ====================== ======================================
d) Aggregated
information
Aggregated
volume Price
18 Ordinary Shares
GBP14.6664
=== ====================== ======================================
e) Date of the 2018-05-10
transaction
=== ====================== ======================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ====================== ======================================
1. Details of PDMR/person closely associated
with them ('PCA')
=== ==============================================================
a) Name Mr S Dingemans
=== ====================== ======================================
b) Position/status Chief Financial Officer
=== ====================== ======================================
c) Initial notification/ Initial notification
amendment
=== ====================== ======================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== ==============================================================
a) Name GlaxoSmithKline plc
=== ====================== ======================================
b) LEI 5493000HZTVUYLO1D793
=== ====================== ======================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== ==============================================================
a) Description Ordinary shares of 25 pence each
of the financial ('Ordinary Shares')
instrument ISIN: GB0009252882
=== ====================== ======================================
b) Nature of Acquisition of Ordinary Shares
the transaction under the Company's Share Reward
Plan.
=== ====================== ======================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------- -----------------------
GBP14.6664 9 (partnership shares)
----------- -----------------------
GBP14.6664 9 (matching shares)
----------- -----------------------
=== ====================== ======================================
d) Aggregated
information
Aggregated
volume Price
18 Ordinary Shares
GBP14.6664
=== ====================== ======================================
e) Date of the 2018-05-10
transaction
=== ====================== ======================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ====================== ======================================
1. Details of PDMR/person closely associated
with them ('PCA')
=== ==============================================================
a) Name Mr N Hirons
=== ====================== ======================================
b) Position/status SVP, Global Ethics & Compliance
=== ====================== ======================================
c) Initial notification/ Initial notification
amendment
=== ====================== ======================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== ==============================================================
a) Name GlaxoSmithKline plc
=== ====================== ======================================
b) LEI 5493000HZTVUYLO1D793
=== ====================== ======================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== ==============================================================
a) Description Ordinary shares of 25 pence each
of the financial ('Ordinary Shares')
instrument ISIN: GB0009252882
=== ====================== ======================================
b) Nature of Acquisition of Ordinary Shares
the transaction under the Company's Share Reward
Plan.
=== ====================== ======================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------- -----------------------
GBP14.6664 9 (partnership shares)
----------- -----------------------
GBP14.6664 9 (matching shares)
----------- -----------------------
=== ====================== ======================================
d) Aggregated
information
Aggregated
volume Price
18 Ordinary Shares
GBP14.6664
=== ====================== ======================================
e) Date of the 2018-05-10
transaction
=== ====================== ======================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ====================== ======================================
1. Details of PDMR/person closely associated
with them ('PCA')
=== ==============================================================
a) Name Mr L Miels
=== ====================== ======================================
b) Position/status President, Global Pharmaceuticals
=== ====================== ======================================
c) Initial notification/ Initial notification
amendment
=== ====================== ======================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== ==============================================================
a) Name GlaxoSmithKline plc
=== ====================== ======================================
b) LEI 5493000HZTVUYLO1D793
=== ====================== ======================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== ==============================================================
a) Description Ordinary shares of 25 pence each
of the financial ('Ordinary Shares')
instrument ISIN: GB0009252882
=== ====================== ======================================
b) Nature of Acquisition of Ordinary Shares
the transaction under the Company's Share Reward
Plan.
=== ====================== ======================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------- -----------------------
GBP14.6664 9 (partnership shares)
----------- -----------------------
GBP14.6664 9 (matching shares)
----------- -----------------------
=== ====================== ======================================
d) Aggregated
information
Aggregated
volume Price
18 Ordinary Shares
GBP14.6664
=== ====================== ======================================
e) Date of the 2018-05-10
transaction
=== ====================== ======================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ====================== ======================================
1. Details of PDMR/person closely associated
with them ('PCA')
=== ==============================================================
a) Name Mr D S Redfern
=== ====================== ======================================
b) Position/status Chief Strategy Officer
=== ====================== ======================================
c) Initial notification/ Initial notification
amendment
=== ====================== ======================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== ==============================================================
a) Name GlaxoSmithKline plc
=== ====================== ======================================
b) LEI 5493000HZTVUYLO1D793
=== ====================== ======================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== ==============================================================
a) Description Ordinary shares of 25 pence each
of the financial ('Ordinary Shares')
instrument ISIN: GB0009252882
=== ====================== ======================================
b) Nature of Acquisition of Ordinary Shares
the transaction under the Company's Share Reward
Plan.
=== ====================== ======================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------- -----------------------
GBP14.6664 9 (partnership shares)
----------- -----------------------
GBP14.6664 9 (matching shares)
----------- -----------------------
=== ====================== ======================================
d) Aggregated
information
Aggregated
volume Price
18 Ordinary Shares
GBP14.6664
=== ====================== ======================================
e) Date of the 2018-05-10
transaction
=== ====================== ======================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ====================== ======================================
1. Details of PDMR/person closely associated
with them ('PCA')
=== ==============================================================
a) Name Ms C Thomas
=== ====================== ======================================
b) Position/status SVP, Human Resources
=== ====================== ======================================
c) Initial notification/ Initial notification
amendment
=== ====================== ======================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== ==============================================================
a) Name GlaxoSmithKline plc
=== ====================== ======================================
b) LEI 5493000HZTVUYLO1D793
=== ====================== ======================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== ==============================================================
a) Description Ordinary shares of 25 pence each
of the financial ('Ordinary Shares')
instrument ISIN: GB0009252882
=== ====================== ======================================
b) Nature of Acquisition of Ordinary Shares
the transaction under the Company's Share Reward
Plan.
=== ====================== ======================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------- -----------------------
GBP14.6664 9 (partnership shares)
----------- -----------------------
GBP14.6664 9 (matching shares)
----------- -----------------------
=== ====================== ======================================
d) Aggregated
information
Aggregated
volume Price
18 Ordinary Shares
GBP14.6664
=== ====================== ======================================
e) Date of the 2018-05-10
transaction
=== ====================== ======================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ====================== ======================================
1. Details of PDMR/person closely associated
with them ('PCA')
=== ==============================================================
a) Name Mr P C Thomson
=== ====================== ======================================
b) Position/status President, Global Affairs
=== ====================== ======================================
c) Initial notification/ Initial notification
amendment
=== ====================== ======================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== ==============================================================
a) Name GlaxoSmithKline plc
=== ====================== ======================================
b) LEI 5493000HZTVUYLO1D793
=== ====================== ======================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== ==============================================================
a) Description Ordinary shares of 25 pence each
of the financial ('Ordinary Shares')
instrument ISIN: GB0009252882
=== ====================== ======================================
b) Nature of Acquisition of Ordinary Shares
the transaction under the Company's Share Reward
Plan.
=== ====================== ======================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------- -----------------------
GBP14.6664 8 (partnership shares)
----------- -----------------------
GBP14.6664 8 (matching shares)
----------- -----------------------
=== ====================== ======================================
d) Aggregated
information
Aggregated
volume Price
16 Ordinary Shares
GBP14.6664
=== ====================== ======================================
e) Date of the 2018-05-10
transaction
=== ====================== ======================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ====================== ======================================
1. Details of PDMR/person closely associated
with them ('PCA')
=== ==============================================================
a) Name Mrs V A Whyte
=== ====================== ======================================
b) Position/status Company Secretary
=== ====================== ======================================
c) Initial notification/ Initial notification
amendment
=== ====================== ======================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== ==============================================================
a) Name GlaxoSmithKline plc
=== ====================== ======================================
b) LEI 5493000HZTVUYLO1D793
=== ====================== ======================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== ==============================================================
a) Description Ordinary shares of 25 pence each
of the financial ('Ordinary Shares')
instrument ISIN: GB0009252882
=== ====================== ======================================
b) Nature of Acquisition of Ordinary Shares
the transaction under the Company's Share Reward
Plan.
=== ====================== ======================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------- -----------------------
GBP14.6664 9 (partnership shares)
----------- -----------------------
GBP14.6664 9 (matching shares)
----------- -----------------------
=== ====================== ======================================
d) Aggregated
information
Aggregated
volume Price
18 Ordinary Shares
GBP14.6664
=== ====================== ======================================
e) Date of the 2018-05-10
transaction
=== ====================== ======================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ====================== ======================================
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHZFLFFVEFFBBX
(END) Dow Jones Newswires
May 11, 2018 10:17 ET (14:17 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
